Clover Health Investments, Corp.
CLOV · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $497 | $478 | $462 | $337 |
| % Growth | 4% | 3.3% | 37.2% | – |
| Cost of Goods Sold | $423 | $378 | $353 | $243 |
| Gross Profit | $73 | $100 | $109 | $94 |
| % Margin | 14.7% | 20.9% | 23.6% | 27.9% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $97 | $110 | $110 | $115 |
| SG&A Expenses | $97 | $110 | $110 | $115 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $98 | $110 | $110 | $115 |
| Operating Income | -$24 | -$11 | -$1 | -$21 |
| % Margin | -4.9% | -2.2% | -0.3% | -6.4% |
| Other Income/Exp. Net | $0 | -$0 | $0 | -$0 |
| Pre-Tax Income | -$24 | -$11 | -$1 | -$21 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$24 | -$11 | -$1 | -$22 |
| % Margin | -4.9% | -2.2% | -0.3% | -6.6% |
| EPS | -0.048 | -0.021 | -0.003 | -0.045 |
| % Growth | -128.4% | -700% | 94.2% | – |
| EPS Diluted | -0.048 | -0.021 | -0.003 | -0.045 |
| Weighted Avg Shares Out | 513 | 509 | 497 | 492 |
| Weighted Avg Shares Out Dil | 513 | 509 | 497 | 492 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$24 | -$10 | -$1 | -$21 |
| % Margin | -4.8% | -2.1% | -0.2% | -6.3% |